XTL Biopharmaceuticals Ltd.
(NASDAQ : XTLB)

( )
XTLB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 2.93%154.100.0%$1239.86m
AMGNAmgen, Inc. 0.00%249.951.3%$706.86m
SNSSSunesis Pharmaceuticals, Inc. 0.00%8.000.7%$559.23m
NVAXNovavax, Inc. -1.08%192.5580.0%$533.83m
ILMNIllumina, Inc. 0.00%403.153.5%$527.32m
GILDGilead Sciences, Inc. -0.06%64.851.0%$472.13m
REGNRegeneron Pharmaceuticals, Inc. 0.51%479.472.7%$433.31m
VRTXVertex Pharmaceuticals, Inc. 0.07%216.101.9%$372.34m
ALXNAlexion Pharmaceuticals, Inc. 0.00%153.732.0%$315.33m
BIIBBiogen, Inc. 0.00%266.191.7%$292.97m
BNTXBioNTech SE 0.09%129.760.0%$219.00m
EXASEXACT Sciences Corp. 1.48%129.8918.4%$197.74m
NBIXNeurocrine Biosciences, Inc. 0.00%92.974.9%$172.50m
CRSPCRISPR Therapeutics AG 0.47%121.450.6%$170.15m
TXG10X Genomics, Inc. 0.00%197.360.0%$149.02m

Company Profile

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.